Zuo Keqiang-河南大学医学院官方网站

Zuo Keqiang, male, 48 years old, Dean of Huaihe Hospital of Henan University, Chief Physician, full-time postgraduate, Doctor of Medicine. He is a member of the Research and Transformation Group of the Endovascular Specialty Branch of the Chinese Medical Doctors Association, a member of the Chinese Branch of the World Union of Venous Diseases, a member of the Internet Medical Branch of the Shanghai Medical Association, a member of the Shanghai Outpatient Management Quality Control Special Committee, a Standing Committee Member of the Medical Consortium Working Committee of the Chinese Hospital Association, a member of the Chinese Association for the Promotion of Human Health Science and Technology (Standing Committee Member and Party Group Leader of the General Outpatient and Emergency Management Professional Committee), and the Acting Director of the Vascular Surgery Committee of the Henan Medical Association. He has published 13 major SCI papers and 6 management articles, and is presiding over 5 ongoing research projects.

(1) Construction of the Digital Quality Management Platform for the Chest Pain Center, a project on technical standardization management and promotion by the Shanghai Shenkang Hospital Development Center, with a funding of 400,000 yuan. Duration: June 1, 2023 - May 31, 2025. SHDC22023223 (Bureau-level project)

(2) Research on the Pathogenic Mechanism of Atherosclerosis in Which LncRNASNHG12 Affects the Senescence of EPCs by Regulating EZH2 and Participates, a General Project of the Natural Science Foundation of Jiangxi Province, with a funding of 100,000 yuan. Duration: January 2023 - January 2026. 20224BAB206016 (Provincial and Ministerial-level project)

(3) Research on the High-quality Integrated Development of Medical Services in the Yangtze River Delta from the Perspective of Trans-regional Loose Medical Consortiums, a project of the Shanghai Philosophy and Social Science Planning Office, with a funding of 80,000 yuan. Duration: November 2023 - November 2025. 2023BGL002 (Provincial and Ministerial-level project)

(4) Research on the Path and Implementation Mode of the Construction of Shanghai Urban Medical Consortiums, a project of the Development Research Center of the Shanghai Municipal People's Government, with a funding of 50,000 yuan. Duration: November 2023 - March 2024. 2023-AZ-26 (Provincial and Ministerial-level project)

(5) Research on Organizational Inertia and Preventive Countermeasures for the High-quality Development of Clinical Specialties in Public Hospitals, the "Guoyi Technology" project of the Hospital Management Institute of Anhui Medical University, with a funding of 20,000 yuan. Duration: January 2025 - December 2026. (Bureau-level project)

1. Zuo KQ, Zhang XP, Zou J, Li D, Lv ZW. Establishment of a paclitaxel-resistant human breast cancer cell strain (MCF-7/Taxol) and analysis of paclitaxel-binding proteins within the cells. The Journal of International Medical Research, 2010; 38(4): 1428-1435.◦ Chinese Academy of Sciences Journal Ranking: Zone 4, Impact Factor: 1.6, First Author

2. Zuo K, Li D, Pulli B, Yu F, Cai H, Yuan X, Zhang X, Lv Z. Short-hairpin RNA-mediated gene silencing of Heat shock protein 90 inhibits the growth of human breast cancer cells both in vitro and in vivo. Biochem Biophys Res Commun. 2012 May 4; 421(2): 396-402.◦ Chinese Academy of Sciences Journal Ranking: Zone 3, Impact Factor: 3.1, First Author

3. Qian ZY, Yang MF, Zuo KQ, Cheng J, Xiao HB, Ding WX. Computed tomography manifestations of common inferior vena cava dysplasia and its clinical significance. Exp Ther Med. 2013 Feb; 5(2): 631-635.◦ Chinese Academy of Sciences Journal Ranking: Zone 4, Impact Factor: 2.8, Corresponding Author

4. Zhang X, Li M, Zuo K, Li D, Ye M, Ding L, Cai H, Fu D, Fan Y, Lv Z. Upregulated miR-155 in papillary thyroid carcinoma promotes tumor growth by targeting APC and activating the Wnt/β-catenin signaling pathway. J Clin Endocrinol Metab. 2013 Aug; 98(8): E1305-13.◦ Chinese Academy of Sciences Journal Ranking: Zone 2, Impact Factor: 5.8, Co-first Author

5. Qian ZY, Yang MF, Zuo KQ, Xiao HB, Ding WX, Cheng J. Protective effects of ulinastatin on intestinal injury during the perioperative period of acute superior mesenteric artery ischemia. Eur Rev Med Pharmacol Sci. 2014; 18(23): 3726-32.◦ Chinese Academy of Sciences Journal Ranking: Zone 4, Impact Factor: 3.3, Corresponding Author

6. Zuo K, Li M, Zhang X, Lu C, Wang S, Zhi K, He B. MiR-21 suppresses the proliferation of endothelial progenitor cells by activating the TGFβ signaling pathway via downregulation of WWP1. Int J Clin Exp Pathol. 2015 Jan 1; 8(1): 414-22.◦ Chinese Academy of Sciences Journal Ranking: Zone 4, Impact Factor: 1.4, First Author

7. Zuo K, Zhi K, Zhang X, Lu C, Wang S, Li M, He B. A dysregulated microRNA-26a/EphA2 axis impairs the function of endothelial progenitor cells via the p38 MAPK/VEGF pathway. Cell Physiol Biochem. 2015; 35(2): 477-88.◦ Chinese Academy of Sciences Journal Ranking: Zone 2, Impact Factor: 5.141, First Author

8. Lu C, Yu X, Zuo K, Zhang X, Cao C, Xu J, Wang S, Tang T, Ye M, Pei E, Uzan G, Zhi K, Li M. Tripterine treatment improves the function of endothelial progenitor cells via integrin-linked kinase. Cell Physiol Biochem. 2015; 37(3): 1089-103.◦ Chinese Academy of Sciences Journal Ranking: Zone 2, Impact Factor: 5.141, Co-first Author

9. Lei Wang, Keqiang Zuo. Medical Data Classification Assisted by Machine Learning Strategy. Comput Math Methods Med. 2022 Sep 10;2022:9699612. Chinese Academy of Sciences Journal Ranking: Zone 4, Impact Factor: 2.809, Corresponding Author

10. Fan W, Zhou M, Zheng S, Liu Y, Pan S, Guo P, Xu M, Hu C, Ding A, Wang Z, Yin S, Zuo K, Xie X. Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Promote Microcirculation in Aged Diabetic Mice via the TGF-β1 Signaling Pathway. Diabetol Metab Syndr. 2023 Nov 15;15(1):234. Chinese Academy of Sciences Journal Ranking: Zone 2, Impact Factor: 4.8, Corresponding Author

11. Anqin Dong, Wenrui Xiao, Weizhong Yuan, Keqiang Zuo. Self-Healable and Injectable Nanocomposite Hydrogel Loading Iron-Doped Carbon Dots for Synergistic Antibacterial Peptide Photothermal-Photodynamic Antibacterial Therapy. ACS Appl. Polym. Mater. 2023, 5, 9564−9573. Chinese Academy of Sciences Journal Ranking: Zone 2, Impact Factor: 5.0, Corresponding Author

12. Zhao Z, Zhang Y, Meng C, Xie X, Cui W, Zuo K. Tissue-penetrating Ultrasound-triggered Hydrogel for Promoting Microvascular Network Reconstruction. Adv Sci. 2024 Apr 10. Chinese Academy of Sciences Journal Ranking: Zone 1, Impact Factor: 15.1 (Corresponding Author)

13. Xu Y, Zhu W, Su Y, Ma T, Zhang Y, Pan X, Huang R, Li Y, Zuo K, Ong SB, Xu D. Characterization of a Novel Mitophagy-related 5-genes Signature for Diagnosis of Acute Myocardial Infarction. Vascul Pharmacol. 2024 Sep;156:107417. doi: 10.1016/j.vph.2024.107417. Epub 2024 Aug 17. Chinese Academy of Sciences Journal Ranking: Zone 2, Impact Factor: 4.0, Corresponding Author

Representative Works on Hospital Management:

1. Zuo Keqiang, Chen Zhen, Sheng Weiqi. Exploration of the Performance Appraisal Mechanism for Outpatient and Emergency Services Based on the Clinical Pathway of Disease Types. Chinese Journal of Health Quality Management, 2020, Issue 05, pp. 31-35. First Author. Core Journal.

2. Wang Qingjiang, Sheng Weiqi, Zuo Keqiang. Real-time Monitoring of Unplanned Second Surgeries Based on the Secondary Development of Electronic Medical Records. Chinese Journal of Health Quality Management, 2020, Issue 01, pp. 51-53. Corresponding Author. Core Journal.

3. Qian Mingping, Zhou Xiaoyuan, Zuo Keqiang. Practice and Enlightenment of the Construction of a Loose Medical Consortium with Multi-subject Collaboration under the Background of the Integration of the Yangtze River Delta. Chinese Journal of Hospital Administration, 2022, 38(6): 411-415. Corresponding Author. Peking University Core Journal.

4. Zuo Keqiang, Hu Longjun, Fei Hongxiang. Analysis of the Development Dilemmas and Countermeasures of the Trans-regional Loose Medical Consortium in the Yangtze River Delta. Chinese Journal of Hospital Administration, 2023, 39(11): 799-803. First Author. Peking University Core Journal.

5. Niu Peiqin, Hu Longjun, Zuo Keqiang. Research on the Performance Appraisal System of Chief Physicians Based on Target Management and Developmental Performance Appraisal. Chinese Journal of Hospital Management, 2024, 44(07): 63-66. Corresponding Author. Peking University Core Journal.

6. Hu Longjun, Huang Jianhua, Zuo Keqiang. Research on the Organizational Inertia of Medical Quality and Safety Management and Its Preventive Strategies. Chinese Journal of Hospital Management, 2025, 45(03): 55-59. Corresponding Author. Peking University Core Journal.

Teachers

Outstanding Talents

Zuo Keqiang Professor

Address

Phone

Postcode

Email